Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: TokyoMex who wrote (15913)	5/8/1998 12:29:00 PM
From: RCJIII	Read Replies (3) \| Respond to of 34592

Is anyone else buying PKGP? Looks interesting. RCJIII

To: TokyoMex who wrote (15913)	5/8/1998 12:31:00 PM
From: Yo Yo	Respond to of 34592

The Micro-Capitalist Research Report Recommends LDNA:OTCBB, $2 Friday, May 08, 1998 at 10:47 AM (OTC BB:LDNA, $2) Lark Announces Quarterly Earnings; Record Revenues in First Quarter 1998; Earnings Increase 35% HOUSTON--May 8, 1998--Lark Technologies, Inc.(OTC BB:LDNA) announced record revenues and earnings for the quarter ended March 31, 1998. Revenues rose to their highest quarterly levels as Lark's contract molecular biology services to major pharmaceutical companies increased during 1998. As a result, revenues increased 24% to $1,378,347 in the first quarter of 1998 from $1,109,671 in the first quarter of 1997. Net income for the first quarter of 1998 was $0.06 per share, as compared to $0.04 per share for the first quarter of 1997. The improved results for the first quarter of 1998 were the outcome of increases in Lark's automated DNA sequencing services and continued operating efficiencies. As noted by Vincent Kazmer, Lark's president, "During the first quarter of 1998, Lark's automated sequencing service business increased for both large-scale and Quick Turnaround services. The market demand for these and other molecular biology services continues to increase in both the US and Europe." Mr. Kazmer stated, "Lark's business is growing and development of new products continues. Operational efficiencies for existing products are good and efficiencies are improving for new products. Our challenge is to continue the growth of the company, continue to improve efficiencies and continue new product development." Lark Technologies, Inc., based in Houston, Texas, is a leading molecular biology contract research organization (CRO) serving the rapidly growing genomics industry. The company was founded in 1989 by BCM Technologies, Inc., the wholly-owned venture, technology transfer subsidiary of Baylor College of Medicine. Lark's stock is quoted on the NASD's OTC Bulletin Board under the symbol "LDNA". Company information is located at its website (www.lark.com).